Limiting the development of anti-cancer drug resistance in a spatial model of micrometastases (Q326548): Difference between revisions

@@ Property / OpenAlex ID @@
+W2962732437
@@ Property / OpenAlex ID: W2962732437 / rank @@
+Normal rank
@@ Property / Wikidata QID @@
+Q38738084
@@ Property / Wikidata QID: Q38738084 / rank @@
+Normal rank
@@ Property / arXiv ID @@
+.03412
@@ Property / arXiv ID: 1601.03412 / rank @@
+Normal rank
@@ Property / cites work @@
+Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers
+Normal rank
@@ Property / cites work @@
+A stochastic model for the origin and treatment of tumors containing drug-resistant cells
+Normal rank
@@ Property / cites work @@
+Evolution of resistance to anti-cancer therapy during general dosing schedules
+Normal rank
@@ Property / cites work @@
+Emergence of Anti-Cancer Drug Resistance: Exploring the Importance of the Microenvironmental Niche via a Spatial Model
+Normal rank
@@ Property / cites work @@
+The impact of cell density and mutations in a model of multidrug resistance in solid tumors
+Normal rank
@@ Property / cites work @@
+A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy
+Normal rank
@@ Property / cites work @@
+Stochastic modeling of cellular colonies with quiescence: an application to drug resistance in cancer
+Normal rank
@@ Property / cites work @@
+Dynamics and control of a mathematical model for metronomic chemotherapy
+Normal rank
@@ Property / cites work @@
+Drug resistance in cancer chemotherapy as an optimal control problem
+Normal rank
@@ Property / cites work @@
+On the MTD paradigm and optimal control for multi-drug cancer chemotherapy
+Normal rank
@@ Property / cites work @@
+Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors
+Normal rank
@@ Property / cites work @@
+Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies
+Normal rank